Lisa Jones is Senior Lecturer in Psychiatry in the School of Clinical and Experimental Medicine.
Lisa is the Principal Investigator of the Mood Disorders Research Group. The broad aims of the group are to investigate genetic and other factors that may contribute to the aetiology of bipolar disorder/manic depression and other related psychotic illnesses, such as schizoaffective disorder and postpartum psychosis. She is Lead for the Psychiatry research theme in the Section of Translational Neuroscience.
Lisa contributes widely to education within the College, particularly to the MBChB degree. She has set up an innovative and popular intercalated programme in Psychological Medicine for medical students. Approximately 100 graduates of the programme have resulted in 51 research publications in high quality peer-reviewed journals co-authored by students, and at least 49 student presentations at national and international conferences and 13 national/international prizes won by students.
Lisa is also very involved with student welfare. She was Deputy Head of Student Development & Support for many years, and continues to do a lot of work supporting medical students with mental health problems to successfully complete their degree and qualify as a doctor. She won the Head of School’s and Head of College’s Prizes for excellence in teaching in 2010.
Postgraduate Certificate in Learning and Teaching in Higher Education 2003
PhD Psychiatric Genetics 1999
Membership of the British Psychological Society 1993
BSc (Hons) Psychology 1993
Lisa qualified with a BSc (Hons) in Psychology from the University of Manchester in 1993. She went on to work as a Research Associate in the Department of Psychological Medicine at the University of Wales College of Medicine. She commenced her PhD in Psychiatric Genetics 1995 within the same department, and this was awarded in 1999 when she continued her work as a post-doctoral researcher. She joined the University of Birmingham as a Lecturer in Psychiatry in 2000, and was promoted to Senior Lecturer in 2005.
Programme Lead for the Intercalated BMedSc in Psychological Medicine.
Deputy Chair Internal Ethics Review Committee (Population Sciences and Humanities Intercalated BMedSc programmes).
Module Lead for the Decision-Making module in Year 2 of the MBChB programme.
Lead teacher for medical psychology, Phase 1 MBChB and Graduate Entry Course in Medicine.
Member of the NHS Psychiatry Teaching Academy.
Personal Mentor on the MBChB programme.
Chair, University Primary Appeals Panel.
External Examiner, MBChB programme, University of Manchester.
Lisa enjoys supervising PhD students, and has successfully supervised many students. She is currently supervising Amy Perry who is conducting a prospective follow-up study of pregnant women with bipolar disorder to identify risk factors for postpartum episodes of illness. Lisa also mentors and supports a number of PhD students being supervised by other members of staff within the College of Medical and Dental Sciences.
She also mentors junior members of staff studying the Postgraduate Certificate in Academic Practice (PCAP).
Lisa heads the Mood Disorders Research Group and currently has funding from two of the world’s leading medical research charities – the Wellcome Trust and the Stanley Medical Research Institute. Her research interests lie in the aetiology of major mental illnesses (in particular, bipolar disorder, postpartum psychosis, major unipolar depression and psychosis). She has particular interests in enriching and refining phenotype definitions for molecular genetic studies, and in underlying cognitive and neuropsychological deficits.
She is a founding member and Principal Investigator of the Bipolar Disorder Research Network (BDRN), a group of researchers, clinicians and research participants in the UK involved in investigating the underlying causes of bipolar disorder. BDRN has recruited the largest sample of individuals with bipolar disorder in the world (currently, 6000 and counting) and has detailed and rich clinical data, psychological data and genetic data on all participants.
The exciting and innovative new mood monitoring system True Colours is currently being offered to BDRN members, in collaboration with colleagues at the University of Oxford as part of CoNBRIO – Collaborative Network for Bipolar Research to Improve Outcomes. True Colours is an easy-to-use online technology that enables individuals to monitor their mood prospectively. The system will deliver groundbreaking data to help understand more about how mood symptoms present over time in individuals with bipolar disorder and how they are affected by changes in routines such as sleep.
Chaired the UK Medical Medical Students National Psychiatry Conference, University of Birmingham, February 2014.
Hosted the Annual Conference for Bipolar UK at the University of Birmingham, June 2010.
Academic leadership of Medical Students’ Psychiatry Society (PsychSoc), including the MedMinds initiative (providing mental health education to school children in Birmingham).
Academic leadership of Feel Bright, a Birmingham Medical School initiative to tackle stigma and support medical students with mental health problems. Feel Bright was highlighted as an example of good practice by the General Medical Council in 2013.
Reviewer for the following journals: American Journal of Psychiatry; British Journal of Psychiatry; Bipolar Disorders; Journal of Affective Disorders; Psychiatry Research; Genes, Brain & Behavior; Behavior Genetics; European Psychiatry; Current Molecular Medicine; Comprehensive Psychiatry.
Reviewer for the following grant giving bodies: Wellcome Trust; Medical Research Council (MRC); Economic & Social Research Council (ESRC); Cancer Research UK; Department of Health; Parkinson’s Disease Society; Medical Research Scotland; Parkinson’s UK.
SELECTED PUBLICATIONS SINCE 2009
Total publications 156; h-index 52; m-quotient 2.6; i10-index 117 (correct May 2015)
Jones L, Metcalf A, Gordon-Smith K, Forty L, Perry A, Lloyd J, Geddes JR, Goodwin GM, Jones I, Craddock N and Rogers RD (2105) The prevalence and distribution of gambling problems in bipolar disorder in the United Kingdom. British Journal of Psychiatry [In press]
Gordon-Smith K, Forty L, Chan C, Knott S, Jones I, Craddock N and Jones LA (2015) Rapid cycling as a feature of bipolar disorder and comorbid migraine. Journal of Affective Disorders 175:320-4
Di Florio A, Forty L, Gordon-Smith K, Heron J, Jones L, Craddock N and Jones I (2013) Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 70(2):168-75
Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 43(10):977-83
Welcome Trust Case Control Consortium (2010) Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464(7289):713-20
Craddock N, Jones L, Jones IR, Kirov G, Green EK, Grozeva D, Moskvina V, Nikolov I, Hamshere ML, Vukcevic D, Caesar S, Gordon-Smith K, Fraser C, Russell E, Norton N, Breen G, St Clair D, Collier DA, Young AH, Ferrier IN, Farmer A, McGuffin P, Holmans PA, Wellcome Trust Case Control Consortium (WTCCC), Donnelly P, Owen ML and O’Donovan MC (2010) Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Molecular Psychiatry 15(2):146-53
Jones L, Scott J, Cooper C, Forty L, Smith KG, Sham P, Farmer A, McGuffin P, Craddock N and Jones I (2010)Cognitive style, personality and vulnerability to postnatal depression. British Journal of Psychiatry 196(3):200-5
Forty L, Jones L, Jones I, Smith DJ, Caesar S, Fraser C, Gordon-Smith K, Hyde S and Craddock N (2009) Polarity at illness onset in bipolar I disorder and clinical course of illness. Bipolar Disorders 11(1):82-8